Cargando…
Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study
PURPOSE: Dabigatran is a direct thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation (NVAF). Real-world data about patient preference, satisfaction and convenience in patients in Asia are not available. The study aimed to explore the perception of pati...
Autores principales: | Lee, Young-Soo, Oh, Yong Seog, Choi, Eue-Keun, Chern, Alan Koay Choon, Jiampo, Panyapat, Chutinet, Aurauma, Hanafy, Dicky Armein, Trivedi, Prabhav, Zhai, Dongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640669/ https://www.ncbi.nlm.nih.gov/pubmed/34857666 http://dx.doi.org/10.1136/openhrt-2021-001745 |
Ejemplares similares
-
Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K antagonist treatment to dabigatran
por: Choi, Eue-Keun, et al.
Publicado: (2020) -
Pharmacological treatment in patients with aortic dissection
por: Smedberg, Christian, et al.
Publicado: (2022) -
Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis
por: O'Neill, Francis, et al.
Publicado: (2017) -
Cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment
por: El-Khatib, Layan A, et al.
Publicado: (2020) -
Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)